In drug discovery & design however the current level of hype surrounding generative AI is generating a variety of responses from the pharmaceutical industry and tends to divert attention of the drug R

In the field of drug discovery and design, the current level of enthusiasm surrounding generative AI has elicited diverse reactions within the pharmaceutical industry. This enthusiasm often distracts the drug research and development (R&D) community from the fundamental aspects through which AI algorithms can genuinely contribute value to the process of drug discovery and design.